Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Sequential Chemotherapy vs High Dose Chemotherapy with Stem Cell Support for Primary Breast Cancer
NCT00002772Phase 3Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Jul 1996
- Primary completion
- Feb 2004
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin, paclitaxel, cyclophosphamide, cisplatin, carmustine in breast cancer, sponsored by SWOG Cancer Research Network. Started Jul 1996; status: terminated.
02
Drugs
doxorubicinpaclitaxelcyclophosphamidecisplatincarmustine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002772.